Literature DB >> 9920031

Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients.

M Trendelenburg1, J Marfurt, I Gerber, A Tyndall, J A Schifferli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9920031     DOI： 10.1002/1529-0131(199901)42:1<187::AID-ANR24>3.0.CO;2-U

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  32 in total

1.  Markers of childhood lupus nephritis indicating disease activity.

Authors:  Monika Edelbauer; Sudhir Kshirsagar; Magdalena Riedl; Dieter Haffner; Heiko Billing; Burkhard Tönshoff; Sophia Ross; Jörg Dötsch; Oliver Amon; Henry Fehrenbach; Christian Steuber; Antje Beissert; Josef Hager; Gottfried Wechselberger; Lutz T Weber; Lothar Bernd Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2010-12-22       Impact factor: 3.714

2.  Anti-C1q antibodies in hepatitis C virus infection.

Authors:  D Saadoun; S Sadallah; M Trendelenburg; N Limal; D Sene; J C Piette; J A Schifferli; P Cacoub
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 3.  Antibodies against C1q in patients with systemic lupus erythematosus.

Authors:  Marten Trendelenburg
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

4.  Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.

Authors:  Heikki Julkunen; Susanne Ekblom-Kullberg; Aaro Miettinen
Journal:  Rheumatol Int       Date:  2011-06-26       Impact factor: 2.631

Review 5.  Are anti-C1q antibodies different from other SLE autoantibodies?

Authors:  Matthew C Pickering; Marina Botto
Journal:  Nat Rev Rheumatol       Date:  2010-04-27       Impact factor: 20.543

6.  Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.

Authors:  Chau-Ching Liu; Amy H Kao; Susan Manzi; Joseph M Ahearn
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-08       Impact factor: 5.346

7.  Anti-C1q autoantibodies are linked to autoimmune thyroid disorders in pregnant women.

Authors:  H Vitkova; J Jiskra; D Springer; Z Limanova; Z Telicka; J Bartakova; M Trendelenburg; E Potlukova
Journal:  Clin Exp Immunol       Date:  2016-08-12       Impact factor: 4.330

8.  Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.

Authors:  Leendert A Trouw; Tom W L Groeneveld; Marc A Seelen; Jacques M G J Duijs; Ingeborg M Bajema; Frans A Prins; Uday Kishore; David J Salant; J Sjef Verbeek; Cees van Kooten; Mohamed R Daha
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

9.  Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.

Authors:  N Marto; M L Bertolaccini; E Calabuig; G R V Hughes; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2004-07-29       Impact factor: 19.103

10.  Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients.

Authors:  S Sadallah; C Hess; M Trendelenburg; C Vedeler; M Lopez-Trascasa; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.